Genscript Biotech Corp
HKEX:1548

Watchlist Manager
Genscript Biotech Corp Logo
Genscript Biotech Corp
HKEX:1548
Watchlist
Price: 11 HKD 4.96% Market Closed
Market Cap: 23.1B HKD
Have any thoughts about
Genscript Biotech Corp?
Write Note

Net Margin
Genscript Biotech Corp

-17.5%
Current
-39%
Average
0%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-17.5%
=
Net Income
-177m
/
Revenue
1B

Net Margin Across Competitors

Country CN
Market Cap 23.3B HKD
Net Margin
-18%
Country US
Market Cap 1.3T USD
Net Margin
9%
Country US
Market Cap 201.7B USD
Net Margin
14%
Country US
Market Cap 173.6B USD
Net Margin
18%
Country KR
Market Cap 67.8T KRW
Net Margin
24%
Country CH
Market Cap 38.6B CHF
Net Margin
9%
Country US
Market Cap 39.6B USD
Net Margin
22%
Country US
Market Cap 36.8B USD
Net Margin
9%
Country US
Market Cap 26.9B USD
Net Margin
21%
Country US
Market Cap 23.5B USD
Net Margin
17%
Country US
Market Cap 23.2B USD
Net Margin
21%
No Stocks Found

Genscript Biotech Corp
Glance View

Market Cap
23.3B HKD
Industry
Life Sciences Tools & Services

Genscript Biotech Corp. is a holding company, which engages in the manufacture and sale of life sciences research products and services. The company is headquartered in Nanjing, Jiangsu. The company went IPO on 2015-12-30. The firm operates through four segments. Life Sciences Research Services segment includes gene and peptide synthesis, deoxyribonucleic acid (DNA) and primer synthesis, DNA sequencing, customized antibody production, protein expression and the production of stable cell lines. Preclinical Drug Development Services segment includes protein and antibody engineering, the study of in vitro drug and the study of in vivo drug. Life Sciences Research Catalog Products segment provides antibodies, recombinant proteins, equipment for protein isolation and analysis, molecular biology reagents, peptide, biochemicals and stable cell lines. Industrial Synthetic Biology Products segment is engaged in the development and production of industrial enzymes.

Intrinsic Value
32.97 HKD
Undervaluation 67%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-17.5%
=
Net Income
-177m
/
Revenue
1B
What is the Net Margin of Genscript Biotech Corp?

Based on Genscript Biotech Corp's most recent financial statements, the company has Net Margin of -17.5%.